Risk Of Obesity
-
{
- All
- News
- Videos
- Web Stories
-
On Ozempic Or Wegovy? Doctors Say Stop Before Surgery, Here's Why
The ASA guidance suggests that patients on GLP-1 drugs should consult their healthcare providers well in advance of any planned surgery.
-
Think Your Liver Is Healthy? 74% Of Indians With 'Normal' Results Actually Have Fatty Liver, Reveals Apollo Report
The finding challenges long-held assumptions around what "normal" really means in preventive healthcare and raises critical concerns about the country's metabolic health.
-
Popular Weight Loss Drugs May Lead To More Muscle Loss, Finds Study
The study analysed multiple studies and found that muscle-related tissue accounted for about 35% of total weight lost in incretin groups, exceeding safe benchmarks in two-thirds of cases.
-
Alcohol Vs Non-Alcoholic Fatty Liver: What's More Dangerous? Know Here
Fatty liver disease caused by alcohol is known as alcoholic fatty liver disease (AFLD). However, when the cause of the disease is not alcohol, it is known as non-alcoholic fatty liver disease (NAFLD).
-
Rising Liver Cancer Cases: Are We Ignoring The Warning Signs? Doctor Answers
The rising incidence of liver cancer across the globe is becoming an alarming public health concern. Once considered relatively uncommon in many regions, liver cancer cases are now increasing steadily due to a combination of lifestyle factors, chroni
-
Ozempic Might Preserve Lean Body Mass Better Than Mounjaro: Study
Both tirzepatide and semaglutide belong to a class of drugs that mimic hormones involved in appetite regulation. Semaglutide works by mimicking GLP-1, a hormone that helps control hunger and blood sugar levels.
-
Obesity Affects Men And Women Differently: Study Reveals Hidden Health Risks, Differences
A new study on obesity reveals that it affects men and women differently. Here are the hidden health risks and differences in how obesity can impact men and women.
-
Top 3 Causes Of Fatty Liver Disease Explained; 5 Prevention Tips To Follow
According to a new Lancet global study, published in The Lancet Gastroenterology & Hepatology, nearly 2 billion people worldwide could be living with metabolic liver disease by 2050.
-
Planning Your Baby's Diet? Nutritionist Shares Foods That Should Be Avoided In The First Year
Nutritionist Nmami Agarwal offers clear guidance on what foods should be avoided to ensure a baby’s healthy and safe development during this critical stage.
-
Got A Buffalo Hump? How It Is A Sign Of A Hidden Health Condition
A buffalo hump is fat accumulation at the neck base that may signal hormonal imbalances like Cushings syndrome or steroid side effects.
-
On Ozempic Or Wegovy? Doctors Say Stop Before Surgery, Here's Why
The ASA guidance suggests that patients on GLP-1 drugs should consult their healthcare providers well in advance of any planned surgery.
-
Think Your Liver Is Healthy? 74% Of Indians With 'Normal' Results Actually Have Fatty Liver, Reveals Apollo Report
The finding challenges long-held assumptions around what "normal" really means in preventive healthcare and raises critical concerns about the country's metabolic health.
-
Popular Weight Loss Drugs May Lead To More Muscle Loss, Finds Study
The study analysed multiple studies and found that muscle-related tissue accounted for about 35% of total weight lost in incretin groups, exceeding safe benchmarks in two-thirds of cases.
-
Alcohol Vs Non-Alcoholic Fatty Liver: What's More Dangerous? Know Here
Fatty liver disease caused by alcohol is known as alcoholic fatty liver disease (AFLD). However, when the cause of the disease is not alcohol, it is known as non-alcoholic fatty liver disease (NAFLD).
-
Rising Liver Cancer Cases: Are We Ignoring The Warning Signs? Doctor Answers
The rising incidence of liver cancer across the globe is becoming an alarming public health concern. Once considered relatively uncommon in many regions, liver cancer cases are now increasing steadily due to a combination of lifestyle factors, chroni
-
Ozempic Might Preserve Lean Body Mass Better Than Mounjaro: Study
Both tirzepatide and semaglutide belong to a class of drugs that mimic hormones involved in appetite regulation. Semaglutide works by mimicking GLP-1, a hormone that helps control hunger and blood sugar levels.
-
Obesity Affects Men And Women Differently: Study Reveals Hidden Health Risks, Differences
A new study on obesity reveals that it affects men and women differently. Here are the hidden health risks and differences in how obesity can impact men and women.
-
Top 3 Causes Of Fatty Liver Disease Explained; 5 Prevention Tips To Follow
According to a new Lancet global study, published in The Lancet Gastroenterology & Hepatology, nearly 2 billion people worldwide could be living with metabolic liver disease by 2050.
-
Planning Your Baby's Diet? Nutritionist Shares Foods That Should Be Avoided In The First Year
Nutritionist Nmami Agarwal offers clear guidance on what foods should be avoided to ensure a baby’s healthy and safe development during this critical stage.
-
Got A Buffalo Hump? How It Is A Sign Of A Hidden Health Condition
A buffalo hump is fat accumulation at the neck base that may signal hormonal imbalances like Cushings syndrome or steroid side effects.
